BECHERINI, CARLOTTA
 Distribuzione geografica
Continente #
NA - Nord America 3.422
AS - Asia 2.516
EU - Europa 2.239
SA - Sud America 286
AF - Africa 48
OC - Oceania 43
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.556
Nazione #
US - Stati Uniti d'America 3.383
RU - Federazione Russa 1.128
CN - Cina 774
SG - Singapore 725
HK - Hong Kong 414
IT - Italia 393
KR - Corea 266
BR - Brasile 234
IE - Irlanda 180
SE - Svezia 129
DE - Germania 116
VN - Vietnam 93
FR - Francia 78
IN - India 74
FI - Finlandia 53
GB - Regno Unito 52
JO - Giordania 47
PL - Polonia 43
AU - Australia 41
ID - Indonesia 33
AR - Argentina 23
CA - Canada 22
NL - Olanda 15
JP - Giappone 14
BD - Bangladesh 12
EC - Ecuador 12
MX - Messico 11
MA - Marocco 9
CH - Svizzera 8
ES - Italia 8
IQ - Iraq 8
UA - Ucraina 8
TR - Turchia 7
ZA - Sudafrica 7
BE - Belgio 6
CI - Costa d'Avorio 6
EG - Egitto 6
VE - Venezuela 6
IL - Israele 5
SC - Seychelles 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
BJ - Benin 4
CO - Colombia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
KZ - Kazakistan 4
PE - Perù 4
PK - Pakistan 4
TN - Tunisia 4
CY - Cipro 3
GR - Grecia 3
KG - Kirghizistan 3
LT - Lituania 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AZ - Azerbaigian 2
CL - Cile 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TJ - Tagikistan 2
AQ - Antartide 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DZ - Algeria 1
GL - Groenlandia 1
KW - Kuwait 1
LB - Libano 1
MT - Malta 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
TH - Thailandia 1
TL - Timor Orientale 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.556
Città #
Santa Clara 1.037
Singapore 519
Hong Kong 372
Ashburn 356
Hefei 312
Seoul 266
Fairfield 207
Chandler 185
Dublin 180
Seattle 123
Woodbridge 117
Beijing 107
Cambridge 91
Wilmington 82
Houston 81
Munich 76
Los Angeles 70
Buffalo 57
Kent 52
Altamura 46
Dearborn 45
Lawrence 43
Moscow 43
Paris 42
Florence 41
Melbourne 38
Ann Arbor 37
Warsaw 37
Shanghai 35
Ho Chi Minh City 34
New York 33
Princeton 31
Mumbai 30
Boston 29
São Paulo 24
Dallas 22
Jakarta 21
Turku 21
Milan 20
San Diego 20
Bengaluru 18
Hanoi 17
Helsinki 17
London 17
Rome 17
Frankfurt am Main 16
Boardman 13
Clifton 12
Naples 12
The Dalles 12
Stockholm 11
Lappeenranta 10
Medford 10
Tokyo 10
Chicago 9
Pune 9
Yubileyny 9
Brooklyn 8
Porto Alegre 8
Redondo Beach 8
West Jordan 8
Guangzhou 7
Quito 7
Rio de Janeiro 7
Salt Lake City 7
Shenzhen 7
Abidjan 6
Brussels 6
Da Nang 6
Poplar 6
Toronto 6
Baghdad 5
Buenos Aires 5
Campinas 5
Curitiba 5
Denver 5
Hillsboro 5
Hải Dương 5
Mexico City 5
Montreal 5
Nanjing 5
Phoenix 5
Somma Vesuviana 5
Tashkent 5
Wroclaw 5
Wuhan 5
Zhengzhou 5
Almaty 4
Bari 4
Belo Horizonte 4
Bexley 4
Bologna 4
Brasília 4
Cotonou 4
Fiesole 4
Goiânia 4
Haiphong 4
Johannesburg 4
Maddaloni 4
Modena 4
Totale 5.430
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 216
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 208
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 207
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 207
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer 207
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 197
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 196
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 192
Influence of age and subtype in outcome of operable liposarcoma 188
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 175
Radiotherapy in the age of cancer immunology: Current concepts and future developments 174
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 174
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 173
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 172
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 167
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 164
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 162
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 159
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 153
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 150
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 147
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 147
Association of Breast Cancer Irradiation with Cardiac Toxic Effects: A Narrative Review 144
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 143
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 143
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 142
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 141
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 140
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 140
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 140
The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study 139
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 138
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 137
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 135
Partial breast irradiation for ductal carcinoma in situ: The Goldilocks principle? 134
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 133
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 132
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 129
Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings 127
Acupuncture for radiation-induced toxicity in head and neck squamous cell carcinoma: a systematic review based on PICO criteria 126
The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation 124
Radiobiology of stereotactic radiotherapy 123
Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art 122
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 119
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 119
Breast reconstruction and radiation therapy: An Italian expert Delphi consensus statements and critical review 119
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 116
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis 108
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review 107
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 107
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trial 105
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 103
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial 99
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 91
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques 90
Radiation therapy on the axilla after neoadjuvant chemotherapy 89
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 83
Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 procedures 80
Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network 78
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 77
Radiomic Analysis for Human Papillomavirus Assessment in Oropharyngeal Carcinoma: Lessons and Pitfalls for the Next Future 61
null 57
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 52
Totale 8.627
Categoria #
all - tutte 27.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021127 0 0 0 0 0 7 9 20 23 27 21 20
2021/2022183 6 8 6 12 5 11 2 23 12 7 27 64
2022/2023867 52 153 49 24 67 153 103 92 120 4 27 23
2023/2024606 28 46 61 36 45 83 43 141 22 28 52 21
2024/20253.533 100 306 155 523 919 471 74 277 177 108 156 267
2025/20262.438 465 586 550 383 448 6 0 0 0 0 0 0
Totale 8.627